Back to Search Start Over

AXL in metastatic ovarian cancer tumors is a targetable biomarker associated with chemoresistance and poor prognosis

Authors :
C.K. McCourt
J.M. Quinn
Premal H. Thaker
G. Opara
A.R. Hagemann
M. Greenwade
H. Beck-Noia
David G. Mutch
Ian S. Hagemann
Mary M. Mullen
K.C. Fuh
L.M. Kuroki
M.A. Powell
Source :
Gynecologic Oncology. 154:79-80
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Details

ISSN :
00908258
Volume :
154
Database :
OpenAIRE
Journal :
Gynecologic Oncology
Accession number :
edsair.doi...........c18531e4a80e091686e090d2f1c26015
Full Text :
https://doi.org/10.1016/j.ygyno.2019.04.188